FDA Approved: ARISTADA INITIO — Supplemental Application (Alkermes, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Aristada Initio (aripiprazole lauroxil) from Alkermes, adding an initiation option for schizophrenia treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• ARISTADA INITIO (ARIPIPRAZOLE LAUROXIL)

Snippet

SUPPL AP for ARISTADA INITIO (ARIPIPRAZOLE LAUROXIL)